Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30273471 | 0.94 | ALDH1A1 (0.38) | ALDH1A1SIGMAR1TSHR | |
| SCHEMBL15789500 | 0.86 | ALDH1A1 (0.31) | ALDH1A1 | |
| Hydrochloric Acid SCHEMBL7942364 | 0.84 | ALDH1A1 (0.52) | ALDH1A1SIGMAR1TSHRDNM1EPHX1 | |
| Hydrochloric Acid SCHEMBL7941281 | 0.82 | ALDH1A1 (0.56) | ALDH1A1SIGMAR1TSHRDNM1EPHX1 | |
| Hydrochloric Acid SCHEMBL7945726 | 0.82 | ALDH1A1 (0.56) | ALDH1A1SIGMAR1TSHRDNM1EPHX1 | |
| Hydrochloric Acid SCHEMBL27163203 | 0.82 | ALDH1A1 (0.56) | ALDH1A1SIGMAR1TSHRDNM1EPHX1 | |
| SCHEMBL31634363 | 0.81 | SIGMAR1 (0.42) | ALDH1A1SIGMAR1TSHRDNM1EPHX1 | |
| Hydrochloric Acid SCHEMBL28002639 | 0.80 | ALDH1A1 (0.54) | ALDH1A1SIGMAR1TSHRDNM1EPHX1 | |
| SCHEMBL587972 | 0.79 | — | — | |
| SCHEMBL442394 | 0.79 | ALDH1A1 (0.42) | ALDH1A1EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119530206-A | Nucleic acid molecules for tumor treatment | 仁景(苏州)生物科技有限公司 | 2025-02-28 | — | — | CN | disclosed |
| CN-118574936-A | Methods and compositions for protein expression and cell differentiation | 非凡生物有限公司 | 2024-08-30 | — | — | CN | disclosed |
| CN-117693584-A | Engineered meganucleases targeting the human mitochondrial genome | 精密生物科学公司 | 2024-03-12 | — | — | CN | disclosed |
| CN-117479963-A | PEG lipids and lipid nanoparticles | 盖纳万科学有限公司 | 2024-01-30 | — | — | CN | disclosed |
| CN-117402852-A | Engineered meganucleases specific for recognition sequences in hepatitis b virus genomes | 精密生物科学公司 | 2024-01-16 | — | — | CN | disclosed |
| CN-117264929-A | Engineered meganucleases with specificity for recognition sequences in the PCSK9 gene | 精密生物科学公司 | 2023-12-22 | — | — | CN | disclosed |
| CN-117177738-A | Tissue-specific nucleic acid delivery by mixed cationic lipid particles | 欧米茄治疗公司 | 2023-12-05 | — | — | CN | disclosed |
| CN-116847832-A | Tissue-specific nucleic acid delivery via 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP) lipid nanoparticles | 欧米茄治疗公司 | 2023-10-03 | — | — | CN | disclosed |
| CN-110769845-B | Engineered meganucleases with specificity for recognition sequences in the PCSK9 gene | 精密生物科学公司 | 2023-08-15 | — | — | CN | disclosed |
| CN-115768438-A | Lipid nanoparticles for delivery of therapeutic agents to the lung | 盖纳万科学有限公司 | 2023-03-07 | — | — | CN | disclosed |